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Results Delayed LV lateral wall activation occurred in 
12/23 patients (maximal LVLW-AT = 133 ± 20 ms [83 ± 5 % 
of QRS duration]). In these patients, the latest activated re-
gion was consistently located on the basal lateral wall. QRS 
duration, and prevalence of QRS fragmentation and left/
right axis deviation, and left anterior/posterior fascicular 
block did not differ between patients with and without de-
layed LV lateral wall activation.
Conclusion Coronary venous electroanatomical mapping 
can be used at the time of CRT implantation to determine 
the presence of delayed LV lateral wall activation in patients 
with IVCD. QRS characteristics on the ECG seem unable to 
identify delayed LV lateral wall activation in this subgroup 
of patients.
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 Background
The supposed mechanism of the benefit of cardiac resyn-
chronisation therapy (CRT) is that delayed activation of the 
left ventricular (LV) lateral wall causes mechanical dys-
function, which can be reverted by paced pre-excitation of 
this delayed LV region. Left bundle branch block (LBBB) is 
typically associated with early septal activation and delayed 
activation of the LV lateral wall [1–3]. Non-specific intra-
ventricular conduction delay (IVCD), on the other hand, 
is considered a more heterogeneous group of conduction 
disorders exhibiting a more variable pattern of ventricular 
electrical activation [3]. This may explain why, in contrast 
to patients with LBBB, patients with IVCD show a variable 
Abstract
Background Delayed left ventricular (LV) lateral wall ac-
tivation is considered the electrical substrate that character-
ises patients suitable for cardiac resynchronisation therapy 
(CRT). Although typically associated with left bundle branch 
block, delayed LV lateral wall activation may also be pres-
ent in patients with non-specific intraventricular conduction 
delay (IVCD). We assessed LV lateral wall activation in a 
cohort of CRT candidates with IVCD using coronary ve-
nous electroanatomical mapping, and investigated whether 
baseline QRS characteristics on the ECG can identify de-
layed LV lateral wall activation in this group of patients.
Methods Twenty-three consecutive CRT candidates with 
IVCD underwent intra-procedural coronary venous electro-
anatomical mapping using EnSite NavX. Electrical activa-
tion time was measured in milliseconds from QRS onset and 
expressed as percentage of QRS duration. LV lateral wall 
activation was considered delayed if maximal activation 
time measured at the LV lateral wall (LVLW-AT) exceeded 
75 % of the QRS duration. QRS morphology, duration, frag-
mentation, axis deviation, and left anterior/posterior fascic-
ular block were assessed on baseline ECGs.
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response to CRT [4]. The reduced benefit of CRT observed 
in this subgroup of patients has led international guidelines 
to assign a lower level of recommendation to CRT in patients 
with IVCD [5]. However, recent studies have suggested that 
CRT may be beneficial in a subset of IVCD patients with 
evidence of LV activation delay [6–9]. Recently, we intro-
duced coronary venous electroanatomical mapping as a tool 
to assess LV electrical activation at the time of CRT implan-
tation in patients with LBBB [10].
The objectives of the present study were [1] to investigate 
whether coronary venous electroanatomical mapping can be 
used at the time of CRT implantation to determine the pres-
ence of delayed LV lateral wall activation in patients with 
IVCD, and [2] to investigate whether QRS characteristics on 
the ECG, other than QRS morphology, can identify delayed 
LV lateral wall activation as determined by coronary venous 
electroanatomical mapping in this subgroup patients.
Methods
Study population
Twenty-three consecutive patients referred for CRT device 
implantation, with LV ejection fraction (LVEF) < 35 %, New 
York Heart Association (NYHA) functional class II, III or 
ambulatory IV, and IVCD with QRS duration ≥ 120 ms were 
enrolled. IVCD was defined as a QRS duration ≥ 120 ms 
without typical features of LBBB or RBBB, according to 
accepted criteria [11]. The study protocol was approved by 
the Institutional Review Board.
Electroanatomical mapping
Coronary venous 3D electroanatomical mapping was per-
formed at the time of CRT implantation as described previ-
ously [10]. In brief, prior to LV lead placement, a 0.014 inch 
guidewire (Vision Wire, Biotronik SE & Co.KG), which 
permits unipolar sensing and pacing, was inserted into the 
coronary sinus and connected to an EnSite NavX system 
(St Jude Medical, St Paul, MN, USA). The guidewire was 
manipulated to all coronary sinus branches located on the 
inferolateral or anterolateral LV wall as defined by the Amer-
ican Heart Association (AHA) 17-segment heart model 
[12], creating an anatomic map along with determining 
local electrical activation time during intrinsic ventricular 
activation. Local activation time was measured in millisec-
onds (ms) from QRS onset on surface ECG and expressed 
as percentage of total QRS duration. Activation of the LV 
lateral wall was considered delayed if maximal activation 
time measured at the LV lateral wall (maximal LVLW-AT) 
exceeded 75 % of the total QRS duration. This definition 
was chosen because epicardial mapping via the coronary 
veins is limited by coronary venous anatomy, which means 
that some areas cannot be mapped because they do not con-
tain any veins. Therefore, the latest activated LV region can 
only be identified using coronary venous mapping by relat-
ing the electrical activation time of the anatomical region to 
its time point within the QRS complex. We believe that an 
electrical activation time exceeding 75 % of QRS duration 
is a reasonable definition for delayed LV lateral wall acti-
vation, especially since previous studies have shown that 
positioning of the LV lead over a region of the heart with an 
electrical delay of just over 50 % of the total QRS duration 
is associated with a superior CRT outcome [9, 13].
After the mapping procedure, the LV lead was positioned in 
or as close as possible to the region of maximal electrical delay 
based on current evidence and recommendations [14, 15].
ECG assessment
Twelve-lead ECGs were assessed by two experienced cli-
nicians blinded to patient data and mapping results. Any 
disagreement was reviewed together before achieving con-
sensus. QRS duration was assessed in the lead with the wid-
est QRS. The QRS axis was derived from the automatically 
computed value on the ECG. Left and right axis deviation, 
as well as the presence of left anterior and posterior fascicu-
lar block, were defined according to AHA/ACC/HRS crite-
ria [11], excluding the criterion of QRS duration < 120 ms 
because of coexisting IVCD. QRS fragmentation was 
defined according to Das et al. [16]; > 2 notches in at least 
2 contiguous leads, or multiple notches in the R wave, or 
> 2 notches in the nadir of the S wave. The region of notch-
ing was classified as anterior when observed in leads V1–5, 
inferior when observed in II, III, aVF and lateral when 
observed in leads I, aVL, V6.
Statistical analysis
Continuous variables are expressed as mean ± standard 
deviation and were compared using the Mann-Whitney 
U test. Categorical variables are expressed as observed num-
bers and percentage values, and were compared using Fish-
er’s exact test. Statistical significance was accepted at the 
95 % confidence interval (p < 0.05). Statistical analysis was 
performed using SPSS version 22.0 (SPSS Inc.) software.
Results
Patient characteristics
Twenty-three patients with IVCD referred for CRT implan-
tation were included in this study. The patient characteris-
tics are presented in Table 1.
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and inferolateral wall were mapped, but delayed activation 
could not be measured in either vein.
ECG parameters in patients with and without delayed LV 
lateral wall activation
The ECG characteristics of patients with and without 
delayed LV lateral wall activation are presented in Table 3. 
QRS duration did not differ between patients with and with-
out delayed LV lateral wall activation. Neither was there a 
difference in the prevalence of left axis deviation, right axis 
deviation, left anterior fascicular block, left posterior fascic-
ular block or QRS fragmentation between patients with and 
without delayed LV lateral wall activation. There was also 
no difference in the distribution of the regions with QRS 
fragmentation between the two groups.
Discussion
Delayed activation of the LV lateral wall is considered the 
electrical substrate underlying LV dysfunction amenable to 
CRT, and may be present in patients without LBBB QRS 
morphology [6, 17]. The present study demonstrates that 
coronary venous electroanatomical mapping can be used 
at the time of CRT implantation to determine the presence 
of delayed LV lateral wall activation and specify the latest 
activated region in CRT candidates with IVCD. Delayed LV 
lateral wall activation was found in approximately half of 
the patients. In patients with delayed activation, the location 
of the latest activated region was practically confined to the 
‘basal’ lateral wall, whereas patients without delayed activa-
tion showed a more heterogeneous distribution of the lat-
est activated region on the LV lateral wall. Baseline 12-lead 
ECG QRS characteristics were not able to identify the pres-
ence of delayed LV lateral wall activation as determined by 
coronary venous electroanatomical mapping.
Results of electroanatomical mapping
Coronary venous electroanatomical mapping was accom-
plished without complications in all patients. A mean 
number of 2.8 ± 0.7 coronary sinus branches were mapped 
during the procedure, of which 1.9 ± 0.5 were located on 
the LV lateral wall. Three-dimensional electrical activation 
maps were generated from 79 ± 18 unique anatomic points. 
Mapping time was 18 ± 5 min, fluoroscopy time during 
the entire procedure 19 ± 4 min, and total radiation dosage 
4031 ± 2064 cGy × cm2.
Delayed LV lateral wall activation, defined as maxi-
mal LVLW-AT exceeding 75 % of the total QRS duration, 
occurred in 12/23 (52 %) patients. In Table 2, LVLW-AT 
data are presented for patients with and without delayed 
LV lateral wall activation. In patients with delayed LV lat-
eral wall activation, maximal LVLW-AT was 133 ± 20 ms 
(83 ± 5 % of QRS duration) and ranged from 103 to 181 ms 
(75–93 % of QRS duration). In patients without delayed LV 
lateral wall activation, maximal LVLW-AT was 100 ± 19 ms 
(64 ± 9 % of QRS duration) and ranged from 69 to 138 ms 
(45–74 % of QRS duration). The number of lateral veins 
that were mapped did not differ between patients with and 
without delayed LV lateral wall activation (p = 0.92). Also, 
baseline characteristics did not differ between the two 
groups. In patients with delayed LV lateral wall activation, 
the most delayed lateral region was more frequently located 
on the ‘basal’ lateral wall than in patients without delayed 
LV lateral wall activation (p = 0.03).
Figure 1 shows examples of coronary venous electroana-
tomical mapping of 2 patients with and without delayed LV 
lateral wall activation. In the example shown in panel A, the 
coronary sinus and three side branches located on the ante-
rior, inferior and inferolateral wall were mapped. Delayed 
activation (139 ms [80 % of QRS duration]) was found in 
the basal region of the inferolateral vein. In the example 
shown in panel B, coronary veins on both the anterolateral 
Table 1 Patient characteristics (n = 23)
Variable Value
Men 16 (64)
Age 72 ± 10





LVEF (%) 29 ± 5
QRS duration (ms) 158 ± 23
Values are in means ± standard deviations or numbers (percentage 
values).
NYHA New York Heart Association, LVEF left ventricular ejection 
fraction.
Table 2 LV lateral wall activation time and latest activated regions in 
patients with and without delayed LV lateral wall activation
Variable Delayed LV acti-
vation (n = 12)
No delayed LV 
activation (n = 11)
P
Maximal LVLW-AT (ms) 133 (± 20) 100 (± 19)
Maximal LVLW-AT (% 
of QRS)
83 (± 5) 64 (± 9)
Region of maximal 
LVLW-AT
Basal anterolateral 7 (58.3) 2 (18.2) 0.09
Basal inferolateral 4 (33.3) 3 (27.3) 1.00
Mid anterolateral 1(8.3) 4 (36.4) 0.16
Mid inferolateral 0 2 (18.2) 0.22
Values are in means ± standard deviations or numbers (percentage 
values).
LVLW-AT left ventricular lateral wall activation time.
Advertisement placed here. 
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Delayed LV lateral wall activation in IVCD patients
The present study demonstrates that coronary venous elec-
troanatomical mapping can be used at the time of CRT 
implantation to identify IVCD patients with delayed LV lat-
eral wall activation.
Detailed 3D LV mapping in patients with IVCD has so 
far been limited to a single case series recently published 
by Ploux et al. [6]. The authors characterised LV epicardial 
electrical activation of 15 IVCD patients referred for CRT 
implantation using non-invasive 3D electrocardiographic 
imaging and found significant LV activation delay in 3 
(20 %) of these patients. Additionally, the presence of LV 
activation delay in IVCD patients was shown to be asso-
ciated with clinical response to CRT. Several other studies 
have also suggested that CRT may be beneficial in a subset 
of non-LBBB patients with evidence of LV activation delay 
[9, 18, 19].
Table 3 ECG parameters in patients with and without delayed activa-
tion of the LV lateral wall
Variable Delayed LVLW 
activation (n = 12)
No delayed LVLW 
activation (n = 11)
P
QRS duration (ms) 159 (± 19) 157 (± 27) 0.46
Left axis deviation 5 (46) 6 (55) 1.00
Right axis deviation 1 (9) 0 1.00
LAFB 4 (36) 6 (55) 0.67
LPFB 1 (9) 0 1.00
QRS fragmentation 7 (64) 5 (46) 0.67
Region of QRS 
fragmentation
Anterior 2 (18) 2 (17) 1.00
Inferior 4 (33) 3 (27) 1.00
Lateral 5 (42) 2 (18) 0.37
Values are in means ± standard deviations or numbers (percentage 
values).
LVLW left ventricular lateral wall, LAFB left anterior fascicular 
block, LPFB left posterior fascicular block.
KEY MESSAGE  Intraprocedural electroanatomical mapping is feasible to show the presence of delayed
left ventricle lateral wall activation in heart failure patients with non-specific intraventricular conduction
delay. Where the ECG does not identify delayed activation of the left ventricular lateral wall, this procedure
can help in selecting patients more likely to respond to cardiac resynchronisation therapy.
Coronary venous electroanatomical mapping of a patient with (A) and without (B)delayed LV lateral wall
activation together with the corresponding 12-lead ECGs (left) local electrical activation time was measured
in milliseconds from QRS onset and projected on the maps using colour coding. Earliest activation is presented
in white and red and latest activation in blue and purple. Grey indicates regions mapped too sparsely to fill data.
AT = electrical activation time, AIV = anterior interventricular vein, MCV = mid cardiac vein, ILV = inferolateral
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myocardial scarring [27]. Yet the majority of these param-
eters have not been validated in patients with ventricular 
conduction disorders. QRS fragmentation has previously 
been shown to indicate the presence of myocardial scarring 
and to predict worse outcome in patients with conduction 
disorders [16, 28]. However, in the present study a signifi-
cant relationship between QRS fragmentation and delayed 
LV lateral wall was not found. These results are in line with 
the findings of two earlier studies that found no relation 
between the presence of QRS fragmentation and echocar-
diographic response to CRT [29, 30].
Limitations
The present study demonstrates the presence of delayed 
LV lateral wall activation in approximately 50 % of IVCD 
patients. Admittedly, the study lacks data on acute haemo-
dynamic response and long-term clinical outcome. Whether 
delayed LV lateral wall activation is also associated with 
CRT response in this group of patients needs to be confirmed 
in subsequent, larger and long-term follow-up studies. The 
small sample size of this study precludes extrapolating the 
results in our cohort of IVCD patients to larger populations. 
Nevertheless, the study population was large enough to 
demonstrate the feasibility of coronary venous electroana-
tomical mapping to determine the presence of delayed LV 
lateral wall activation in CRT candidates with IVCD.
Conclusion
Coronary venous electroanatomical mapping can be used at 
the time of CRT implantation to identify IVCD patients with 
delayed LV lateral wall activation, who are more likely to 
benefit from CRT. Baseline QRS characteristics on the ECG 
seem unable to identify delayed LV lateral wall activation in 
this subgroup of patients.
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Latest activated region
In patients with delayed LV lateral wall activation, the 
region of latest activation was similar to that observed in 
previous mapping studies of patients with LBBB [2, 3, 6, 
20]. This observation suggests the presence of a conduction 
disturbance at a similar level of that observed in patients 
with LBBB despite the absence of a typical LBBB morphol-
ogy on surface ECG. On the other hand, in patients without 
delayed LV lateral wall activation, the location of the latest 
activated region was more heterogeneous, which suggests 
that QRS widening in these patients may have a different 
underlying aetiology such as LV hypertrophy, LV enlarge-
ment, myocardial fibrosis or conduction disturbances 
located more distally than the usual sites at the bundle 
branches [3]. These findings correspond with the results of 
a recent study by Eschalier et al. who characterised a subset 
of patients with IVCD that had ventricular conduction prop-
erties similar to that of LBBB patients, but did not display 
typical LBBB characteristics on the 12-lead ECG [21].
Diagnostic performance of ECG parameters for delayed 
LV lateral wall activation
Patient selection in CRT has been primarily based on a wide 
QRS complex [5]. Yet in the present study we found that a 
larger QRS duration was not associated with delayed LV 
lateral wall activation in patients with IVCD. This may be 
explained by the fact that QRS duration is merely a surface 
depiction of biventricular depolarisation time, sensitive to 
conduction delay in either the left or right ventricle.
With respect to the frontal QRS axis, neither left nor 
right axis deviation was associated with delayed LV lateral 
wall activation in the present study. Especially the lack of 
delayed LV lateral wall activation in patients with left axis 
deviation was remarkable, as this is considered a sign of LV 
involvement in conduction delay. A possible explanation for 
this finding is that in heart failure patients, axis deviation 
may often be the result of a change in the anatomical posi-
tion of the heart due to for instance LV dilatation, rather 
than an actual change in the vector of electrical conduction 
[22, 23]. Although even more specific for left ventricular 
conduction delay, in this study neither anterior nor poste-
rior fascicular block was associated with the presence of 
delayed LV lateral wall activation.
Given the fact that the presence of myocardial scar 
and ischaemic cardiomyopathy in a more broader sense 
have been shown to reduce the likelihood of a favourable 
response to CRT [24–26], we hypothesised that ECG mark-
ers of myocardial scarring/fibrosis have an inverse relation-
ship with delayed LV lateral wall activation. Various ECG 
parameters have been related to the presence or extent of 
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